Status:
UNKNOWN
Oxygen Requirements and Use in Patients With COVID-19 in LMICs
Lead Sponsor:
Pryanka Relan
Conditions:
Covid19
COVID-19 Pneumonia
Eligibility:
All Genders
12+ years
Brief Summary
This observational cohort study will enroll patients in LMICs with suspected or confirmed COVID-19 on oxygen or deemed to require oxygen therapy based on objective criteria. Demographics and risk fact...
Detailed Description
The COVID-19 pandemic has highlighted, more than ever, the acute need for scale up of oxygen therapy. WHO has provided an inventory tool to quantify facility-level provision of infrastructure to deliv...
Eligibility Criteria
Inclusion
- Suspected SARS-CoV-2 infection as determined by treating clinical provider, or confirmed SARS-CoV-2 infection confirmed virologically in the lab by RT-PCR via nasopharyngeal or oropharyngeal sample or by SARS-CoV-2 Ag-RDTs that meet the minimum performance requirements of ≥80% sensitivity and ≥97% specificity compared to a NAAT reference assay.
- Receiving supplemental oxygen or showing clinical evidence of need for supplemental respiratory support as reflected in a respiratory rate ≥30 breaths per minute or an SpO2 ≤ 90%, SpO2 \< 94 % if any emergency signs are present
- Admitted to health care facility
Exclusion
- Is not receiving oxygen or does not have clinical criteria for oxygen treatment specified above oxygen therapy
- Does not have suspected or confirmed COVID-19 (as per criteria above)
- Patient younger than 12 years of age
- Lack of commitment to full supportive care
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2023
Estimated Enrollment :
2400 Patients enrolled
Trial Details
Trial ID
NCT04918875
Start Date
January 1 2022
End Date
October 30 2023
Last Update
August 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
World Health Organization
Geneva, Other, Switzerland, 1202